AbbVie-allied ADARx aims for IPO with 3 drugs in the clinicnews2026-09-05T07:42:51+00:00September 5th, 2026|Endpoints News|
The race to make new Ebola vaccines faces a cash crunchnews2026-09-04T15:34:26+00:00September 4th, 2026|Endpoints News|
US-China biotech NeuShen gets $80M to develop brain-health drugsnews2026-09-04T14:47:16+00:00September 4th, 2026|Endpoints News|
Ionis wins FDA approval of Alexander disease drug zilganersennews2026-09-04T14:46:03+00:00September 4th, 2026|Endpoints News|
Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assetsnews2026-09-04T12:00:51+00:00September 4th, 2026|Endpoints News|
Italy’s Menarini gets into obesity with European rights to GLP-1 from China’s Gan & Leenews2026-09-04T10:44:21+00:00September 4th, 2026|Endpoints News|
Merck’s top dealmaker signals more M&A as Keytruda’s patent cliff nearsnews2026-09-03T18:49:58+00:00September 3rd, 2026|Endpoints News|
Novartis’ drug delivery deal with Alteogen; More worker cuts at Cellaresnews2026-09-03T15:30:42+00:00September 3rd, 2026|Endpoints News|
Pfizer shares ADC rights with Medicus; RevMed updates lung cancer datanews2026-09-03T15:19:01+00:00September 3rd, 2026|Endpoints News|
AbbVie claims Phase 3 win for multiple myeloma drug etentamignews2026-09-03T14:50:40+00:00September 3rd, 2026|Endpoints News|
